Nutex Health (NASDAQ:NUTX) Downgraded to “Buy” Rating by Wall Street Zen

Nutex Health (NASDAQ:NUTX) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report released on Monday.

Other analysts have also recently issued research reports about the company. B. Riley Financial started coverage on Nutex Health in a research report on Friday, June 26th. They issued a “buy” rating and a $290.00 target price for the company. Zacks Research raised Nutex Health to a “hold” rating in a research report on Monday, June 29th. Weiss Ratings downgraded Nutex Health from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, July 10th. Finally, Lake Street Capital started coverage on Nutex Health in a research report on Tuesday, June 2nd. They set a “buy” rating and a $235.00 price objective for the company. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, Nutex Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $243.33.

Nutex Health Stock Performance

Nutex Health stock opened at $162.98 on Monday. The company has a 50 day moving average price of $148.90 and a 200 day moving average price of $130.69. Nutex Health has a 52 week low of $77.21 and a 52 week high of $204.00. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.12 and a current ratio of 3.14. The firm has a market capitalization of $1.12 billion, a price-to-earnings ratio of 12.60 and a beta of 0.21.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, topping the consensus estimate of $3.99 by $2.53. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. The firm had revenue of $216.49 million for the quarter, compared to analysts’ expectations of $227.80 million. Research analysts forecast that Nutex Health will post 22.72 EPS for the current year.

Institutional Trading of Nutex Health

Several large investors have recently added to or reduced their stakes in the business. Topline Capital Management LLC lifted its position in shares of Nutex Health by 72.0% in the second quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock worth $38,484,000 after buying an additional 129,418 shares during the last quarter. Millennium Management LLC increased its holdings in shares of Nutex Health by 191.1% during the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after acquiring an additional 61,308 shares during the last quarter. Pertento Partners LLP raised its stake in shares of Nutex Health by 20.0% in the 4th quarter. Pertento Partners LLP now owns 324,422 shares of the company’s stock valued at $53,406,000 after acquiring an additional 54,001 shares in the last quarter. Empowered Funds LLC acquired a new position in Nutex Health during the first quarter valued at approximately $3,084,000. Finally, SG Americas Securities LLC grew its stake in Nutex Health by 3,232.6% in the 1st quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock valued at $2,885,000 after buying an additional 29,449 shares during the last quarter. 5.32% of the stock is owned by institutional investors.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.